Výsledky vyhledávání

Autor: Shigeru, Negi, Mami, Hamori, Hiroaki, Kitagishi, Yukio, Sugiura

Publikováno v: 同志社大学ハリス理化学研究報告 = The Harris science review of Doshisha University. 63(4):227-234

ジンクフィンガータンパク質は，ヒトプロテオーム中に豊富に存在し，様々な機能に関与している．ジンクフィンガータンパク質の生物学的重要性，その機能向上や生物学的応用を目的�

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=jairo_______::84f93410fb230ea2b5ad9d73af9034b2
http://id.nii.ac.jp/1707/00029401/

Zobrazit plný text záznamu

グルタチオンによるジスルフィド結合の還元反応に対する微量金属の関与

Autor: Shigeru, Negi, Mami, Hamori, Rina, Hashimoto, Yuka, Nakagawa-Kawahara, Hiroaki, Kitagishi, Yukio, Sugiura

Publikováno v: 同志社大学ハリス理化学研究報告 = The Harris science review of Doshisha University. 63(1):45-49

グルタチオン(GSH)を還元剤として用い，亜鉛フィンガータンパク質を還元反応の基質として，構造中にシスチンを含む酸化タンパク質の還元における微量金属元素の影響を調べた。ショ�

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=jairo_______::b19f5eb7c95e77a75b283cca7e2130e6
http://id.nii.ac.jp/1707/00028926/

Zobrazit plný text záznamu

Pharmacokinetic–Pharmacodynamic Analysis of Cisplatin with Hydration and Mannitol Diuresis: The Contribution of Urine Cisplatin Concentration to Nephrotoxicity

Autor: Asako Nishimura, Mika Hirasaki, Keizo Fukushima, Mami Hamori, Akira Okada, Nobuyuki Sugioka, Hiroyuki Oe, Nobuhito Shibata

Publikováno v: European Journal of Drug Metabolism and Pharmacokinetics. 43:193-203

Forced diuresis, high-volume hydration with diuresis, is widely used as a prophylactic treatment against cisplatin nephrotoxicity. However, the details of the underlying mechanisms and the optimal protocol of forced diuresis remain unclear. The prese

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a584389122e23cd57cecf244bed3e3ff
https://doi.org/10.1007/s13318-017-0436-8

Zobrazit plný text záznamu

Alterations in Cisplatin Pharmacokinetics and Its Acute/Sub-chronic Kidney Injury over Multiple Cycles of Cisplatin Treatment in Rats

Autor: Nobuhito Shibata, Asako Nishimura, Mai Fujita, Keizo Fukushima, Mami Hamori, Nobuyuki Sugioka, Akira Okada, Mana Nakanishi

Publikováno v: Biologicalpharmaceutical bulletin. 40(11)

Cisplatin (CDDP)-induced acute kidney injury (AKI) is a major clinical concern. CDDP treatment is generally conducted with multiple cycles; the magnitude of the CDDP-induced AKI may be altered by these cycles. Moreover, sub-chronic kidney injury (sCK

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75d0c62a13789d3afb7af15edd2d5c9b
https://pubmed.ncbi.nlm.nih.gov/29093343

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání